Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice?

被引:19
|
作者
Tyrer, Peter [1 ]
Seivewright, Helen [1 ]
Simmonds, Shaeda [1 ]
Johnson, Tony [2 ]
机构
[1] Paterson Ctr, London W2 1PD, England
[2] MRC, Biostat Unit, Cambridge CB2 2BW, England
关键词
Anxiety; depression; comorbidity; classification; outcome;
D O I
10.1007/BF03035128
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We suggest that the diagnosis of mixed anxiety depression at syndromal level (i.e. both anxiety and depressive diagnoses present in the same person and given equal status) is valuable clinically and should be introduced into the formal classification of neurotic and mood disorders. Evidence is given from a systematic review that cothymia has a significantly worse outcome than either an anxiety or a depressive diagnosis alone (p < 0.0001). Long-term follow-up data in a 12-year outcome study of neurotic disorder reinforce this finding both with regard to social functioning and the clinical course of anxiety and depressive disorders; these were significantly worse (P < 0.001 and P < 0.02 respectively) in those with cothymia compared with single anxiety disorders. These outcome differences are much greater than those between anxiety and depressive disorders alone.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 50 条
  • [31] Treatment of mixed anxiety-depression disorder:: Long-term outcome
    Echeburúa, E
    Salaberría, K
    de Corral, P
    Cenea, R
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2006, 34 (01) : 95 - 101
  • [32] CLINICAL AND THERAPEUTIC APPROACH TO ANXIETY-DEPRESSION SYNDROMES - EFFECTIVENESS OF BROMAZEPAM
    DACHARY, JM
    ROUSSEAU, C
    NOUVELLE PRESSE MEDICALE, 1982, 11 (22): : 1710 - 1712
  • [33] CHRONIC ANXIETY - GENERALIZED ANXIETY DISORDER AND MIXED ANXIETY-DEPRESSION (VOL 150, PG 518, 1993)
    RAPEE, RM
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (05): : 848 - 848
  • [34] Prevalence rates of depression in studies of head and neck cancer patients across the treatment trajectory: How do they inform practice?
    Haisfield-Wolfe, Mary Ellen
    McGuire, Deborah
    Soeken, Karen
    Geiger-Brown, Jeanne
    DeForge, Bruce
    ONCOLOGY NURSING FORUM, 2008, 35 (03) : 512 - 512
  • [35] Efficacy of Silexan in mixed anxiety-depression - A randomized, placebo-controlled trial
    Kasper, Siegfried
    Volz, Hans-Peter
    Dienel, Angelika
    Schlaefke, Sandra
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 331 - 340
  • [36] CLINICAL ANALYSIS ON DEANXIT TREATING UNSTABLE ANGINA PATIENTS WITH ANXIETY-DEPRESSION
    Cai Jiu-mei
    Xie Dong-yang
    HEART, 2012, 98 : E286 - E286
  • [37] The interaction of reinforcement sensitivity and life events in the prediction of anhedonic depression and mixed anxiety-depression symptoms
    Hundt, Natalie E.
    Nelson-Gray, Rosemery O.
    Kimbrel, Nathan A.
    Mitchell, John T.
    Kwapil, Thomas R.
    PERSONALITY AND INDIVIDUAL DIFFERENCES, 2007, 43 (05) : 1001 - 1012
  • [38] Mixed anxiety-depression as DSM-IV-research diagnosis: Problems and perspectives
    Neumer, SP
    Becker, E
    Margraf, J
    Rose, U
    Soeder, U
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2000, 35 (3-4) : 14 - 14
  • [40] Tandospirone in the treatment of generalised anxiety disorder and mixed anxiety-depression - Results of a comparatively high dosage trial
    Nishitsuji, K
    To, H
    Murakami, Y
    Kodama, K
    Kobayashi, D
    Yamada, T
    Kubo, C
    Mine, K
    CLINICAL DRUG INVESTIGATION, 2004, 24 (02) : 121 - 126